Recombinant human parathyroid hormone

Recombinant human parathyroid hormone, marketed under the trade name Natpara, is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism.[1][2]

References
  1. "FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". fda.gov. Retrieved 30 January 2015.
  2. "Natpara Approval History". drugs.com. Retrieved 30 January 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.